MENU
CLDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Celldex Therapeutics (CLDX) Earnings Date & Reports

Celldex Therapeutics Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CLDX is expected to report earnings to rise 6.59% to -75 cents per share on May 01

Celldex Therapeutics CLDX Stock Earnings Reports
Q1'25
Est.
$-0.76
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.15
The last earnings report on February 27 showed earnings per share of -70 cents, missing the estimate of -68 cents. With 121.53K shares outstanding, the current market capitalization sits at 1.15B.
View a ticker or compare two or three
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of immunotherapy technologies for the treatment of cancer and other diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
160
Web
https://www.celldex.com